Amir A Jazaeri

Associate Professor

  • 3728 Citations
  • 25 h-Index
1992 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Ovarian Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Endometrial Neoplasms Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Uterine Cervical Neoplasms Medicine & Life Sciences
Transcriptome Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

  • 3728 Citations
  • 25 h-Index
  • 56 Article
  • 6 Review article
  • 3 Comment/debate
  • 2 Editorial

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury

Abu-Sbeih, H., Tang, T., Lu, Y., Thirumurthi, S., Altan, M., Jazaeri, A. A., Dadu, R., Coronel, E. & Wang, Y., Feb 6 2019, In : Journal for immunotherapy of cancer. 7, 1, 502.

Research output: Contribution to journalArticle

Open Access
Wounds and Injuries
Lipase
Pancreatitis
Chronic Pancreatitis
Recurrence

Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis

Abu-Sbeih, H., Ali, F. S., Wang, X., Mallepally, N., Chen, E., Altan, M., Bresalier, R., Charabaty, A., Dadu, R., Jazaeri, A. A., Lashner, B. & Wang, Y., Apr 2 2019, In : Journal for immunotherapy of cancer. 7, 1, 93.

Research output: Contribution to journalArticle

Open Access
Colitis
Immunosuppressive Agents
Steroids
Therapeutics
Hospitalization

A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice

Jazaeri, A. A., Coleman, R., Sood, A. K., Frumovitz, M., Soliman, P. T., Shafer, A., Cutrera, J. J., Klinger, M., Sharafi, S. E., Johnson, C. A. L., Villanueva, V. F., Hinchcliff, E. M., Dickens, A., Cain, K. E., Anderson, J. E., Lu, K. H. & Westin, S. N., Nov 1 2018, In : Gynecologic oncology. 151, 2, p. 374-380 7 p.

Research output: Contribution to journalReview article

Immunotherapy
Pharmaceutical Preparations
Neoplasms
Therapeutics
Clinical Trials
1 Citation (Scopus)

Characteristics and outcomes of patients with recurrent ovarian cancer undergoing early phase immune checkpoint inhibitor clinical trials

Hinchcliff, E., Hong, D. S., Le, H., Chisholm, G., Iyer, R. B., Naing, A., Hwu, P. & Jazaeri, A. A., Dec 1 2018, In : Gynecologic oncology. 151, 3, p. 407-413 7 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Clinical Trials
Platinum
Disease-Free Survival
Liver
4 Citations (Scopus)

Diagnosis and Management of Immune Checkpoint Inhibitor–related Toxicities in Ovarian Cancer: A Series of Case Vignettes

Johnson, C. & Jazaeri, A. A., Mar 1 2018, In : Clinical Therapeutics. 40, 3, p. 389-394 6 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Programmed Cell Death 1 Receptor
CTLA-4 Antigen
Neoplasms
Immunotherapy